MannKind Corp logo

MannKind Corp

MNKD
Healthcare|Biotechnology|USA
$4.09
-0.05 (-1.21%)

Analyst Estimates

annual
{ "date": [ "202612", "202712", "202812", "202912", "203012" ], "revenue_estimate": [ 462.51, 521.8, 535.1, 607.4, 702.48 ], "ebit_estimate": [ 57.41, 97.11, 93.36, 151.74, 225.91 ], "ebitda_estimate": [ null, null, null, null, null ], "net_income_estimate": [ -4.97, 45.41, 47.49, 94.21, 152.62 ], "per_share_eps_estimate": [ 0, 0.14, 0.14, 0.28, 0.45 ], "eps_nri_estimate": [ 0, 0.14, 0.14, 0.28, 0.45 ], "dividend_estimate": [ null, null, null, null, null ], "book_value_per_share_estimate": [ null, null, null, null, null ], "pretax_income_estimate": [ -3.27, 43.04, 39.55, 106.6, 200.84 ], "operating_cash_flow_per_share_estimate": [ null, null, null, null, null ], "roa_estimate": [ null, null, null, null, null ], "roe_estimate": [ null, null, null, null, null ], "gross_margin_estimate": [ 75.3, 76.93, 77.73, 76.65, 75.5 ], "operating_cash_flow_estimate": [ null, null, null, null, null ], "pettm_estimate": [ 0, 30.07, 28.4, 14.56, 9.03 ], "long_term_growth_rate_mean": 0, "long_term_revenue_growth_rate_mean": "15.06", "future_per_share_eps_estimate_growth": null, "future_eps_nri_estimate_growth": null, "future_revenue_estimate_growth": 15.06, "future_ebit_estimate_growth": 37.16, "future_ebitda_estimate_growth": null, "future_dividend_estimate_growth": null, "future_net_income_estimate_growth": null, "future_pretax_income_estimate_growth": null, "future_book_value_per_share_estimate_growth": null, "future_roa_estimate_growth": null, "future_roe_estimate_growth": null, "future_gross_margin_estimate_growth": 1.85, "future_operating_cash_flow_per_share_estimate_growth": null }
quarterly
{ "date": [ "202606", "202609", "202612", "202703", "202706", "202709", "202712" ], "revenue_estimate": [ 109.37, 120.46, 140.76, 120, 144, 153, 153 ], "ebit_estimate": [ 11.84, 18.38, 26.86, 8, 58, 65, 25 ], "ebitda_estimate": [ null, null, null, null, null, null, null ], "net_income_estimate": [ -0.56, 3.86, 10.24, -3, 47, 53, 18 ], "per_share_eps_estimate": [ 0, 0.01, 0.03, -0.01, 0.15, 0.17, 0.06 ], "eps_nri_estimate": [ 0, 0.01, 0.03, -0.01, 0.15, 0.17, 0.06 ], "dividend_estimate": [ null, null, null, null, null, null, null ], "book_value_per_share_estimate": [ null, null, null, null, null, null, null ], "pretax_income_estimate": [ 0.31, 2.36, 10.95, -1, 49, 56, 16 ], "operating_cash_flow_per_share_estimate": [ null, null, null, null, null, null, null ], "roa_estimate": [ null, null, null, null, null, null, null ], "roe_estimate": [ null, null, null, null, null, null, null ], "gross_margin_estimate": [ 73.8, 74.1, 74.57, null, null, null, null ], "operating_cash_flow_estimate": [ null, null, null, null, null, null, null ], "pettm_estimate": [ 136.33, 22.72, 12.06, 11.05, null, null, null ], "long_term_growth_rate_mean": 0, "long_term_revenue_growth_rate_mean": "15.06", "future_per_share_eps_estimate_growth": null, "future_eps_nri_estimate_growth": null, "future_revenue_estimate_growth": 15.06, "future_ebit_estimate_growth": 37.16, "future_ebitda_estimate_growth": null, "future_dividend_estimate_growth": null, "future_net_income_estimate_growth": null, "future_pretax_income_estimate_growth": null, "future_book_value_per_share_estimate_growth": null, "future_roa_estimate_growth": null, "future_roe_estimate_growth": null, "future_gross_margin_estimate_growth": 1.85, "future_operating_cash_flow_per_share_estimate_growth": null }